Skip to main content

Day: March 12, 2021

TARONIS FUELS ISSUES STATEMENT

Urges Shareholders to Sign GREEN Consent Revocation Card and NOT Return any WHITE Consent Solicitation CardsPeoria, AZ, March 12, 2021 (GLOBE NEWSWIRE) — Taronis Fuels, Inc. (“Taronis” or “the Company”) (OTCQB:TRNF), a global producer of renewable and socially responsible fuel products, issued the following statement in response to a letter sent by Thomas Wetherald and Tobias Welo (“Wetherald/Welo”) who are seeking to remove, without cause, all five members of the Company’s Board of Directors.“Taronis shareholders should not be misled by the false information being disseminated by the Welo/Wetherald activist group. The activist’s diatribe of manufactured grievances is nothing more than an attempt to distract shareholders from the fact that they are trying to steal the company, to take control without paying shareholders for it.”“Taronis...

Continue reading

Ayr Wellness Provides Outlook for 2022

TORONTO, March 12, 2021 (GLOBE NEWSWIRE) — Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“Ayr” or the “Company”), a vertically-integrated cannabis multi-state operator (MSO), on March 11, 2021 in connection with its fourth quarter and year-end 2020 results, provided an outlook for 2022, which included target revenues of US$725 million and Adjusted EBITDA (see “Non-IFRS Measures below) of US$325 million. As 2021 is expected to be a transitional year, no outlook is being provided for 2021.In developing the guidance set forth above, Ayr made the following assumptions and relied on the following factors and considerations (as well as those referred to under “Forward-Looking Information” below):The targets are subject to the timing of pending M&A transactions:Arizona and Ohio will close by the end of Q1 2021New Jersey will close...

Continue reading

Skyline Announces Operational Results for the Year Ended December 31, 2020

2020 revenue from Skyline’s hotels and resorts was $91.5 million compared to $193.6 million in 2019, a decline of 53% due to the impact of COVID-19;Skyline’s operating expenses from hotels and resorts also declined by 47%, including the effect of subsidies received in response to the pandemic;2020 EBITDA remained positive at $7.9 million versus $40.8 million in 2019;Unrestricted cash and available lines of credit as at December 31, 2020 totalled approximately $27 million;Occupancy of all of the Company’s US hotels and Canadian resorts show a steady seasonally-adjusted improvement from their lows in April;The Company received all required debt waivers and extensions needed during 2020, with Midroog reconfirming the Company’s debt rating at Baa1 (with Negative Outlook);During 2020, the Company achieved final closing of its Second Nature Phase...

Continue reading

Diana Shipping Inc. Announces the Filing of Its 2020 Annual Report on Form 20-F

ATHENS, Greece, March 12, 2021 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership of dry bulk vessels, today announced that it has filed its 2020 Annual Report on Form 20-F with the United States Securities and Exchange Commission. The Annual Report is available for download on the Company’s website, www.dianashippinginc.com. Any shareholder may receive a hard copy of the Company’s complete Annual Report, which includes the Company’s 2020 audited financial statements, free of charge upon request.About the CompanyDiana Shipping Inc. is a global provider of shipping transportation services through its ownership of dry bulk vessels. The Company’s vessels are employed primarily on medium to long-term time charters and transport a range of dry bulk cargoes, including...

Continue reading

Ocugen to Host Conference Call on Thursday, March 18 at 8:30 a.m. ET to Discuss 2020 Financial Results and Provide a Business Update

MALVERN, Pa., March 12, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen”) (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it will host a conference call to discuss its 2020 financial results and provide a business update at 8:30 a.m. ET on Thursday, March 18, 2021.Ocugen will issue a pre-market earnings announcement the same day. Investors are invited to participate on the call using the following details:About Ocugen, Inc.Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. Our breakthrough modifier gene therapy platform has...

Continue reading

Etrion Releases 2020 Results

GENEVA, March 12, 2021 (GLOBE NEWSWIRE) — Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, released today its annual consolidated financial statements, related management’s discussion and analysis (“MD&A”) and annual information form (“AIF”) for the year ended December 31, 2020.2020 HIGHLIGHTSCorporateThe Company engaged Mitsubishi UFJ Morgan Stanley Securities Co., Ltd (“MUMSS”) in summer of 2020 as financial advisor to assist with the potential sale of the Japanese solar assets. During the third quarter of 2020, the Company received several non-binding proposals from strategic and financial investors regarding the potential purchase of the solar projects and a short-listed group of interested parties were selected to engage in detailed due diligence of the...

Continue reading

ETC Announces Results of the Annual Meeting of Shareholders’ Vote

SOUTHAMPTON, Pa., March 12, 2021 (GLOBE NEWSWIRE) — Environmental Tectonics Corporation (OTC Pink: ETCC) (“ETC” or the “Company”) announced today the results of shareholder voting from its Annual Meeting of Shareholders.ETC’s Annual Meeting of Shareholders was held virtually on Wednesday, March 10, 2021, at 10:00 a.m., with shareholders voting on the following two proposals.The election of Dr. George K. Anderson, Dr. Linda J. Brent, Roger Colley, Robert L. Laurent, Jr., and Winston E. Scott as Directors of the Company from the slate of six nominees.The ratification of the appointment of RSM US LLP as the Company’s independent registered public accounting firm for the fiscal year ended February 26, 2021.With respect to ETC’s Board of Directors, Dr. Anderson will remain Chairman of the Board.The Company’s officers are as follows:...

Continue reading

Value Line, Inc. Announces Third Quarter Earnings

New York, March 12, 2021 (GLOBE NEWSWIRE) —  Value Line, Inc., (NASDAQ: VALU) reported earnings for the third fiscal quarter ended January 31, 2021.During the nine months ended January 31, 2021, the Company’s net income of $16,202,000, or $1.69 per share, was 26.1% above net income of $12,853,000, or $1.33 per share, for the nine months ended January 31, 2020. The largest factors in the increase in net income during the nine months ended January 31, 2021, compared to the prior fiscal year, were an increase in copyright fees, an increase from revenues and profits interests in EAM Trust, and an increase in realized capital gains on sales of securities available for sale.During the three months ended January 31, 2021, the Company’s net income of $6,029,000, or $0.63 per share, was 21.7% above net income of $4,952,000, or $0.51 per share,...

Continue reading

Aben Resources Grants Incentive Stock Options

VANCOUVER, British Columbia, March 12, 2021 (GLOBE NEWSWIRE) — Aben Resources Ltd. (TSX-V: ABN) (OTCQB: ABNAF) (Frankfurt: E2L2) (“Aben” or “the Company”) announces that it has granted 3,398,384 incentive stock options (the “Options”) to its directors, officers, employees and consultants. The Options are exercisable at $0.065 per share for a period of two years from the date of grant. The Options have been granted under and are governed by the terms of the Company’s incentive stock option plan.About Aben Resources:Aben Resources is a Canadian gold exploration company developing gold-focused projects in British Columbia and the Yukon Territory. Aben is a well-funded junior exploration company.Forrest Kerr Gold Project, Golden Triangle, BC claims map:https://abenresources.com/site/assets/files/4087/abn_forrest_kerr_project_map.pdfFor...

Continue reading

Rubius Therapeutics Announces Webcast to Review Initial Clinical Data from Ongoing Phase 1/2 Trial of RTX-240 in Patients with Advanced Solid Tumors

CAMBRIDGE, Mass., March 12, 2021 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™, today announced that the Company plans to issue a pre-market press release and conduct a webcast on Monday, March 15, 2021, to discuss the initial clinical data findings from the ongoing Phase 1/2 trial of RTX-240 in patients with advanced solid tumors.The Company will host a conference call and webcast with a slide presentation at 8:00 a.m. EDT on Monday, March 15th to discuss this update. The link to the webcast of the conference call will be posted on the Investors & Media section of the Company’s website. The update may also be accessed by dialing 1-800-289-0045...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.